CLS Holdings USA Inc (CLSH)
0.0561
0.00 (0.00%)
USD |
OTCM |
May 10, 15:59
CLS Holdings USA Total Liabilities (Quarterly): 20.65M for Feb. 29, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 20.65M |
November 30, 2023 | 26.19M |
August 31, 2023 | 24.53M |
May 31, 2023 | 23.87M |
February 28, 2023 | 23.91M |
November 30, 2022 | 24.02M |
August 31, 2022 | 33.76M |
May 31, 2022 | 32.98M |
February 28, 2022 | 29.99M |
November 30, 2021 | 27.28M |
August 31, 2021 | 26.47M |
May 31, 2021 | 26.69M |
February 28, 2021 | 21.65M |
November 30, 2020 | 21.76M |
August 31, 2020 | 21.45M |
May 31, 2020 | 20.66M |
February 29, 2020 | 19.86M |
November 30, 2019 | 20.78M |
August 31, 2019 | 20.10M |
May 31, 2019 | 21.47M |
February 28, 2019 | 17.33M |
November 30, 2018 | 7.859M |
Date | Value |
---|---|
August 31, 2018 | 6.312M |
May 31, 2018 | 2.733M |
February 28, 2018 | 3.410M |
November 30, 2017 | 2.216M |
August 31, 2017 | 2.113M |
May 31, 2017 | 2.018M |
February 28, 2017 | 3.297M |
November 30, 2016 | 3.160M |
August 31, 2016 | 2.227M |
May 31, 2016 | 1.686M |
February 29, 2016 | 1.203M |
November 30, 2015 | 1.533M |
August 31, 2015 | 1.147M |
May 31, 2015 | 0.8813M |
February 28, 2015 | 0.0072M |
November 30, 2014 | 0.00 |
August 31, 2014 | 0.0366M |
May 31, 2014 | 0.0305M |
February 28, 2014 | 0.0146M |
November 30, 2013 | 0.0112M |
August 31, 2013 | 0.0079M |
May 31, 2013 | 0.0028M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
19.86M
Minimum
Feb 2020
33.76M
Maximum
Aug 2022
24.40M
Average
23.89M
Median
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.130M |
Shareholders Equity (Quarterly) | -10.38M |
Debt to Equity Ratio | -0.6786 |
Current Ratio | 0.3046 |
Net Debt Paydown Yield | 15.81% |